-
1
-
-
0026769510
-
Chiral separation by high performance liquid chromatography: I. Review on indirect separation of enantiomers as diastereomeric derivatives using ultraviolet, fluorescence and electrochemical detection
-
Srinivas NR, Igwemezie LN: Chiral separation by high performance liquid chromatography: I. Review on indirect separation of enantiomers as diastereomeric derivatives using ultraviolet, fluorescence and electrochemical detection. Biomed Chromatogr 1992;6:163.
-
(1992)
Biomed Chromatogr
, vol.6
, pp. 163
-
-
Srinivas, N.R.1
Igwemezie, L.N.2
-
2
-
-
0028894156
-
Gas chromatographic determination of enantiomers as diastereomers following pre-column derivatization and applications to pharmacokinetic studies: A review
-
Srinivas NR, Shyu WC, Barbhaiya RH: Gas chromatographic determination of enantiomers as diastereomers following pre-column derivatization and applications to pharmacokinetic studies: a review. Biomed Chromotogr 1995;9:1.
-
(1995)
Biomed Chromotogr
, vol.9
, pp. 1
-
-
Srinivas, N.R.1
Shyu, W.C.2
Barbhaiya, R.H.3
-
3
-
-
0035061554
-
Chiral derivatization reagents for drug enantioseparation by high-performance liquid chromatography based upon pre-column derivatization and formation of diastereomers: Enantioselectivity and related structure
-
Sun XX, Sun LZ, Aboul-Enein HY: Chiral derivatization reagents for drug enantioseparation by high-performance liquid chromatography based upon pre-column derivatization and formation of diastereomers: enantioselectivity and related structure. Biomed Chromatogr 2001;15(2):116-132.
-
(2001)
Biomed Chromatogr
, vol.15
, Issue.2
, pp. 116-132
-
-
Sun, X.X.1
Sun, L.Z.2
Aboul-Enein, H.Y.3
-
4
-
-
0031798996
-
Recent applications of polysaccharide-type chiral stationary phases for the enantioselective analysis of chiral drugs with one and two stereogenic centers
-
Aboul-Enein HY: Recent applications of polysaccharide-type chiral stationary phases for the enantioselective analysis of chiral drugs with one and two stereogenic centers. Biomed Chromatogr 1998;12:116-119.
-
(1998)
Biomed Chromatogr
, vol.12
, pp. 116-119
-
-
Aboul-Enein, H.Y.1
-
5
-
-
0035847233
-
Chiral separations using the macrocyclic antibiotics: A review
-
Ward TJ, Francis AB III: Chiral separations using the macrocyclic antibiotics: a review. J Chromatogr A 2001;906:73-89.
-
(2001)
J Chromatogr A
, vol.906
, pp. 73-89
-
-
Ward, T.J.1
Francis III, A.B.2
-
6
-
-
0036130597
-
Role of chiral chromatography in therapeutic drug monitoring and in clinical and forensic toxicology
-
Williams ML, Wainer IW: Role of chiral chromatography in therapeutic drug monitoring and in clinical and forensic toxicology. Ther Drug Monitor 2002;24:290-296.
-
(2002)
Ther Drug Monitor
, vol.24
, pp. 290-296
-
-
Williams, M.L.1
Wainer, I.W.2
-
7
-
-
0035847212
-
High-performance liquid chromatographic enantioseparation of drugs containing multiple chiral centers on polysaccharide-type chiral stationary phases
-
Aboul-Enein HY: High-performance liquid chromatographic enantioseparation of drugs containing multiple chiral centers on polysaccharide-type chiral stationary phases. J Chromatogr A 2001;906:185-193.
-
(2001)
J Chromatogr A
, vol.906
, pp. 185-193
-
-
Aboul-Enein, H.Y.1
-
8
-
-
0035847236
-
Reviewing mobile phases used on Chiralcel OD through an application of data mining tools to CHIRBASE database
-
Piras P, Roussel C, Pierrot-Saunders J: Reviewing mobile phases used on Chiralcel OD through an application of data mining tools to CHIRBASE database. J Chromotogr A 2001;906:443-458.
-
(2001)
J Chromotogr A
, vol.906
, pp. 443-458
-
-
Piras, P.1
Roussel, C.2
Pierrot-Saunders, J.3
-
10
-
-
0035824257
-
Separation of enantiomers of ibuprofen on chiral stationary phases by packed column supercritical fluid chromatography
-
Johannsen M: Separation of enantiomers of ibuprofen on chiral stationary phases by packed column supercritical fluid chromatography. J Chromatogr A 2001;937:135-138.
-
(2001)
J Chromatogr A
, vol.937
, pp. 135-138
-
-
Johannsen, M.1
-
11
-
-
0034048114
-
Enantioselective supercritical fluid chromatography using ristocetin A chiral stationary phases
-
Svensson LA, Owens PK: Enantioselective supercritical fluid chromatography using ristocetin A chiral stationary phases. Analyst 2000;125:1037-1039.
-
(2000)
Analyst
, vol.125
, pp. 1037-1039
-
-
Svensson, L.A.1
Owens, P.K.2
-
12
-
-
0034282506
-
Comparison of packed-column supercritical fluid chromatography-tandem mass spectrometry for bioanalytical determination of (R)-and (S)-ketoprofen in human plasma following automated 96-well solid-phase extraction
-
Hoke SH, Pinkston JD, Bailey RE, Tanguay SL, Eichold TH: Comparison of packed-column supercritical fluid chromatography-tandem mass spectrometry for bioanalytical determination of (R)-and (S)-ketoprofen in human plasma following automated 96-well solid-phase extraction. Anal Chem 2000;72:4235-4241.
-
(2000)
Anal Chem
, vol.72
, pp. 4235-4241
-
-
Hoke, S.H.1
Pinkston, J.D.2
Bailey, R.E.3
Tanguay, S.L.4
Eichold, T.H.5
-
13
-
-
0028520084
-
Sub- and supercritical fluid chromatography on packed columns: A versatile tool for the enantioselective separation of basic and acidic drugs
-
Kot A, Sandra P, Venema A: Sub- and supercritical fluid chromatography on packed columns: a versatile tool for the enantioselective separation of basic and acidic drugs. J Chromatogr Sci 1994;32:439-448.
-
(1994)
J Chromatogr Sci
, vol.32
, pp. 439-448
-
-
Kot, A.1
Sandra, P.2
Venema, A.3
-
14
-
-
0037135005
-
Liquid-phase microextraction combined with capillary electrophoresis, a promising tool for the determination of chiral drugs in biological matrices
-
Andersen S, Halvorsen TG, Pedersen-Bjergaard S, Rasmussen KE: Liquid-phase microextraction combined with capillary electrophoresis, a promising tool for the determination of chiral drugs in biological matrices. J Chromatogr A 2002;963:303-312.
-
(2002)
J Chromatogr A
, vol.963
, pp. 303-312
-
-
Andersen, S.1
Halvorsen, T.G.2
Pedersen-Bjergaard, S.3
Rasmussen, K.E.4
-
15
-
-
0034790295
-
Separation of basic drugs enantiomers by capillary electrophoresis using ovoglycoprotein as a chiral selector: Comparison of chiral resolution ability of ovoglycoprotein and completely deglycosylated ovoglycoprotein
-
Matsunga H, Haginaka J: Separation of basic drugs enantiomers by capillary electrophoresis using ovoglycoprotein as a chiral selector: comparison of chiral resolution ability of ovoglycoprotein and completely deglycosylated ovoglycoprotein. Electrophoresis 2001;22:3252-3256.
-
(2001)
Electrophoresis
, vol.22
, pp. 3252-3256
-
-
Matsunga, H.1
Haginaka, J.2
-
16
-
-
0032749158
-
FDA policy and regulation of stereoisomers: Paradigm shift and the future of safer, more effective drugs
-
Strong M: FDA policy and regulation of stereoisomers: paradigm shift and the future of safer, more effective drugs. Food Drug Law J 1999;54:463-487.
-
(1999)
Food Drug Law J
, vol.54
, pp. 463-487
-
-
Strong, M.1
-
17
-
-
0023639698
-
Bias in pharmacokinetics and clinical pharmacology
-
Ariens EJ, Wuis EW: Bias in pharmacokinetics and clinical pharmacology. Clin Pharmacol Ther 1987;42:361.
-
(1987)
Clin Pharmacol Ther
, vol.42
, pp. 361
-
-
Ariens, E.J.1
Wuis, E.W.2
-
18
-
-
0026484986
-
The importance of stereochemistry in drug action and disposition
-
Caldwell J: The importance of stereochemistry in drug action and disposition. J Clin Pharmacol 1992;32:925-929.
-
(1992)
J Clin Pharmacol
, vol.32
, pp. 925-929
-
-
Caldwell, J.1
-
19
-
-
0028019730
-
Chirality in new drug development: Clinical pharmacokinetic considerations
-
Nation RL: Chirality in new drug development: clinical pharmacokinetic considerations. Clin Pharmacokin 1994;27:249-255.
-
(1994)
Clin Pharmacokin
, vol.27
, pp. 249-255
-
-
Nation, R.L.1
-
20
-
-
0034820056
-
Enantiomeric drug development: Issues, considerations, and regulatory requirements. Invited Min-Review
-
Srinivas NR, Barbhaiya RH, Midha KK: Enantiomeric drug development: issues, considerations, and regulatory requirements. Invited Min-Review. J Pharm Sci 2001;90(9):1205-1215.
-
(2001)
J Pharm Sci
, vol.90
, Issue.9
, pp. 1205-1215
-
-
Srinivas, N.R.1
Barbhaiya, R.H.2
Midha, K.K.3
-
21
-
-
0026445535
-
Stereochemistry and bioequivalence
-
Jamali F: Stereochemistry and bioequivalence. J Clin Pharmacol 1992;32:930-934.
-
(1992)
J Clin Pharmacol
, vol.32
, pp. 930-934
-
-
Jamali, F.1
-
22
-
-
0026492324
-
From controversy to resolution: Bioequivalency of racemic drugs-a symposium on the dynamics, kinetics, bioequivalency, and analytical aspects of stereochemistry
-
Wechter WJ: From controversy to resolution: bioequivalency of racemic drugs-a symposium on the dynamics, kinetics, bioequivalency, and analytical aspects of stereochemistry. J Clin Pharmacol 1992;32:915-916.
-
(1992)
J Clin Pharmacol
, vol.32
, pp. 915-916
-
-
Wechter, W.J.1
-
24
-
-
0026683718
-
Enantioselective versus non-enantioselective assays in comparative bioavailability studies with racemic drugs
-
Hooper WD, Dickinson RG, Gal J: Enantioselective versus non-enantioselective assays in comparative bioavailability studies with racemic drugs. Biopharm Drug Disp 1992;13:383-387.
-
(1992)
Biopharm Drug Disp
, vol.13
, pp. 383-387
-
-
Hooper, W.D.1
Dickinson, R.G.2
Gal, J.3
-
25
-
-
0026773812
-
Enantioselective versus non-enantioselective assays in comparative bioavailability studies for racemic drugs
-
Jamali F: Enantioselective versus non-enantioselective assays in comparative bioavailability studies for racemic drugs. Biopharm Drug Disp 1992;13:385.
-
(1992)
Biopharm Drug Disp
, vol.13
, pp. 385
-
-
Jamali, F.1
-
26
-
-
0030018387
-
Enantioselective assays in comparative bioavailability studies of racemic drug formulations: Nice to know or need to know
-
Karim A: Enantioselective assays in comparative bioavailability studies of racemic drug formulations: nice to know or need to know. J Clin Pharmacol 1996;36:490-499.
-
(1996)
J Clin Pharmacol
, vol.36
, pp. 490-499
-
-
Karim, A.1
-
27
-
-
0030851895
-
Bioequivalence of chiral drugs: Stereospecific versus non-stereospecific methods
-
Mehvar R, Jamali F: Bioequivalence of chiral drugs: stereospecific versus non-stereospecific methods. Clin Pharmacokin 1997;33:122-141.
-
(1997)
Clin Pharmacokin
, vol.33
, pp. 122-141
-
-
Mehvar, R.1
Jamali, F.2
-
28
-
-
0033840256
-
Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: Possible involvement of CYP2D and CYP3A
-
Niwa T, Shiraga T, Mitani Y, Terakawa M, Tokuma Y, Kagayama A: Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Drug Metob Dispos 2000;28:1128-1134.
-
(2000)
Drug Metob Dispos
, vol.28
, pp. 1128-1134
-
-
Niwa, T.1
Shiraga, T.2
Mitani, Y.3
Terakawa, M.4
Tokuma, Y.5
Kagayama, A.6
-
29
-
-
0035103370
-
Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin
-
Tanaka M, Ohkubo T, Otani K, Suzuki A, Kaneko S, Sugawara K, et al: Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin. Clin Pharmacol Ther 2001;69:108.
-
(2001)
Clin Pharmacol Ther
, vol.69
, pp. 108
-
-
Tanaka, M.1
Ohkubo, T.2
Otani, K.3
Suzuki, A.4
Kaneko, S.5
Sugawara, K.6
-
30
-
-
0032954533
-
Stereoselective disposition of the antiarrhythmic agent mexiletine during the concomitant administration of caffeine
-
Labbe L, Abolfathi Z, Robitaille NM, St. Maurice F, Gilbert M, Turgeon J: Stereoselective disposition of the antiarrhythmic agent mexiletine during the concomitant administration of caffeine. Ther Drug Monitor 1999;21:191.
-
(1999)
Ther Drug Monitor
, vol.21
, pp. 191
-
-
Labbe, L.1
Abolfathi, Z.2
Robitaille, N.M.3
St. Maurice, F.4
Gilbert, M.5
Turgeon, J.6
-
31
-
-
0034935013
-
Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole
-
Andersson T, Hassan-Alin M, Hasselgren G, Rohss K, Weidolf L: Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole. Clin Pharmacokin 2001;40:411-426.
-
(2001)
Clin Pharmacokin
, vol.40
, pp. 411-426
-
-
Andersson, T.1
Hassan-Alin, M.2
Hasselgren, G.3
Rohss, K.4
Weidolf, L.5
-
32
-
-
0033786474
-
Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin
-
Haritos VS, Ghabiral H, Ahokas JT, Ching MS: Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin. Pharmacogenetics 2000;10:591.
-
(2000)
Pharmacogenetics
, vol.10
, pp. 591
-
-
Haritos, V.S.1
Ghabiral, H.2
Ahokas, J.T.3
Ching, M.S.4
-
33
-
-
0034075099
-
Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?
-
Rasmussen BB, Brosen K: Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors? Ther Drug Monitor 2000;22:143.
-
(2000)
Ther Drug Monitor
, vol.22
, pp. 143
-
-
Rasmussen, B.B.1
Brosen, K.2
-
34
-
-
0035660655
-
Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes
-
Katsuki H, Hamada A, Nakamura C, Arimori K, Nakano M: Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes. Eur J Clin Pharmacol 2001;57:709-715.
-
(2001)
Eur J Clin Pharmacol
, vol.57
, pp. 709-715
-
-
Katsuki, H.1
Hamada, A.2
Nakamura, C.3
Arimori, K.4
Nakano, M.5
-
35
-
-
0032440352
-
The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: Studies in stereoselective hydroxylation and population pharmacokinetics
-
Mamiya K, Leiri I, Shimamoto J, Yukawa E, Imai J, Ninomiya H, et al: The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics. Epilepsia 1998;39:1317.
-
(1998)
Epilepsia
, vol.39
, pp. 1317
-
-
Mamiya, K.1
Leiri, I.2
Shimamoto, J.3
Yukawa, E.4
Imai, J.5
Ninomiya, H.6
-
36
-
-
0030941088
-
Plasma levels of citalopram enantiomers and metabolites in elderly patients
-
Foglia JP, Pollock BG, Kirshner MA, Rosen J, Sweet R, Mulsant B: Plasma levels of citalopram enantiomers and metabolites in elderly patients. Pyschopharmacol Bull 1997;33:109.
-
(1997)
Pyschopharmacol Bull
, vol.33
, pp. 109
-
-
Foglia, J.P.1
Pollock, B.G.2
Kirshner, M.A.3
Rosen, J.4
Sweet, R.5
Mulsant, B.6
-
37
-
-
0033668829
-
Dose proportional and stereospecific pharmacokinetics of methylphenidate delivered using an osmotic controlled release oral delivery system
-
Modi NB, Wang B, Noveck RJ, Gupta SK: Dose proportional and stereospecific pharmacokinetics of methylphenidate delivered using an osmotic controlled release oral delivery system. J Clin Pharmacol 2000;40:1141.
-
(2000)
J Clin Pharmacol
, vol.40
, pp. 1141
-
-
Modi, N.B.1
Wang, B.2
Noveck, R.J.3
Gupta, S.K.4
-
39
-
-
0024854898
-
Enantioselective aspects of the disposition of dl-threo-methylphenidate after the administration of a sustained-release formulation to children with attention deficit-hyperactivity disorder
-
Hubbard JW, Srinivas NR, Quinn D, Midha KK: Enantioselective aspects of the disposition of dl-threo-methylphenidate after the administration of a sustained-release formulation to children with attention deficit-hyperactivity disorder. J Pharm Sci 1989;78:944.
-
(1989)
J Pharm Sci
, vol.78
, pp. 944
-
-
Hubbard, J.W.1
Srinivas, N.R.2
Quinn, D.3
Midha, K.K.4
-
40
-
-
0036227517
-
Influence of input rate on the stereospecific and nonstereospecific first pass metabolism and pharmacokinetics of metoprolol extended release formulations
-
Mistry B, Leslie JL, Eddington ND: Influence of input rate on the stereospecific and nonstereospecific first pass metabolism and pharmacokinetics of metoprolol extended release formulations. Chirality 2002;14:297-304.
-
(2002)
Chirality
, vol.14
, pp. 297-304
-
-
Mistry, B.1
Leslie, J.L.2
Eddington, N.D.3
-
41
-
-
0030773341
-
Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers
-
Aberg J, Abrahamsson B, Grind M, Nyberg G, Olofsson B: Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers. Eur J Clin Pharmacol 1997;52:471-477.
-
(1997)
Eur J Clin Pharmacol
, vol.52
, pp. 471-477
-
-
Aberg, J.1
Abrahamsson, B.2
Grind, M.3
Nyberg, G.4
Olofsson, B.5
-
42
-
-
0025734474
-
Comparative bioavailability of two flurbiprofen products: Stereospecific versus conventional approach
-
Jamali F, Collins DS, Berry BW, Molder S, Cheung R, McColl K, et al: Comparative bioavailability of two flurbiprofen products: stereospecific versus conventional approach. Biopharm Drug Disp 1991;12:435-445.
-
(1991)
Biopharm Drug Disp
, vol.12
, pp. 435-445
-
-
Jamali, F.1
Collins, D.S.2
Berry, B.W.3
Molder, S.4
Cheung, R.5
McColl, K.6
-
43
-
-
0006340099
-
Alterations in apparent bioequivalency of ibuprofen based on isomer analysis
-
Walker SE, Hardy BG: Alterations in apparent bioequivalency of ibuprofen based on isomer analysis. J Clin Pharmacol 1992;32:957.
-
(1992)
J Clin Pharmacol
, vol.32
, pp. 957
-
-
Walker, S.E.1
Hardy, B.G.2
-
44
-
-
0023812439
-
Comparative human study of ibuprofen enantiomer plasma comcentrations produced by two commercially available ibuprofen tablets
-
Cox SR, Brown MA, Squires DJ, Murrill EA, Lednicer D, Knuth DW: Comparative human study of ibuprofen enantiomer plasma comcentrations produced by two commercially available ibuprofen tablets. Biopharm Drug Disp 1988;9:539-549.
-
(1988)
Biopharm Drug Disp
, vol.9
, pp. 539-549
-
-
Cox, S.R.1
Brown, M.A.2
Squires, D.J.3
Murrill, E.A.4
Lednicer, D.5
Knuth, D.W.6
-
45
-
-
9044226528
-
Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: Assessment using stereospecific and nonstereospecific assays
-
Srinivas NR, Barr WH, Shyu WC, Mohandoss E, Chow S, Staggers J, et al: Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: assessment using stereospecific and nonstereospecific assays. J Pharm Sci 1996;85:299.
-
(1996)
J Pharm Sci
, vol.85
, pp. 299
-
-
Srinivas, N.R.1
Barr, W.H.2
Shyu, W.C.3
Mohandoss, E.4
Chow, S.5
Staggers, J.6
-
46
-
-
0029962695
-
The roles of stereochemistry and partial areas in a parallel design study to assess the bioequivalence of two formulations of hydroxychloroquine: A drug with a very long half life
-
Midha KK, Hubbard JW, Rawson MJ, Schwede R: The roles of stereochemistry and partial areas in a parallel design study to assess the bioequivalence of two formulations of hydroxychloroquine: a drug with a very long half life. Eur J Pharm Sci 1996;4:283-292.
-
(1996)
Eur J Pharm Sci
, vol.4
, pp. 283-292
-
-
Midha, K.K.1
Hubbard, J.W.2
Rawson, M.J.3
Schwede, R.4
-
47
-
-
0030012868
-
The impact of stereoisomerism in a bioequivalence study on two formulations of doxepin
-
Midha KK, Hubbard JW, Rawson MJ, Schwede R: The impact of stereoisomerism in a bioequivalence study on two formulations of doxepin. Eur J Pharm Sci 1996;4:133-138.
-
(1996)
Eur J Pharm Sci
, vol.4
, pp. 133-138
-
-
Midha, K.K.1
Hubbard, J.W.2
Rawson, M.J.3
Schwede, R.4
-
48
-
-
0034495319
-
Chiral bioequivalence: Effect of absorption rate on racemic etodolac
-
Boni JR, Korth-Bradley JM, Richards LS, Chiang ST, Hicks DR, Benet LZ: Chiral bioequivalence: effect of absorption rate on racemic etodolac. Clin Pharmacokin 2000;39:459.
-
(2000)
Clin Pharmacokin
, vol.39
, pp. 459
-
-
Boni, J.R.1
Korth-Bradley, J.M.2
Richards, L.S.3
Chiang, S.T.4
Hicks, D.R.5
Benet, L.Z.6
-
49
-
-
0033926605
-
Stereospecific versus nonstereospecific assessments for the bioequivalence of two formulations of racemic chlorpheniramine
-
Bui TH, Fernandez C, Vu K, Nguyen KH, Thuillier A, Farinotti R, et al: Stereospecific versus nonstereospecific assessments for the bioequivalence of two formulations of racemic chlorpheniramine. Chirality 2000;12:599-605.
-
(2000)
Chirality
, vol.12
, pp. 599-605
-
-
Bui, T.H.1
Fernandez, C.2
Vu, K.3
Nguyen, K.H.4
Thuillier, A.5
Farinotti, R.6
-
50
-
-
0031660137
-
Which bioequivalence study for a racemic drug? Application to milnacipran
-
Deprez D, Chassard D, Baille P, Mignot A, Ung HL, Puozzo C: Which bioequivalence study for a racemic drug? Application to milnacipran. Eur J Drug Metob Pharmacokin 2000;23:166.
-
(2000)
Eur J Drug Metob Pharmacokin
, vol.23
, pp. 166
-
-
Deprez, D.1
Chassard, D.2
Baille, P.3
Mignot, A.4
Ung, H.L.5
Puozzo, C.6
|